It's known that Amyloidβ is accumulated in the brain of Alzheimer's disease (AD) patients. Insoluble fibrils made by aggregated Amyloidβ form plaques inducing nerve cell mutations to develop AD and is called the “Amyloid Hypothesis”. However, a recent new hypothesis called “low molecular weight Amyloidβ toxic oligomer hypothesis” is more widely accepted. Download the white paper "Trend of Toxic Amyloidβ Oligomer Hypothesis" to learn the latest discoveries.